"Dr. Ibrahim M. El-Sherbiny is currently a professor specializing in nano and materials sciences at the University of Science and Technology, and acts as director of nano and materials sciences programs and a joint director of the Center for Materials Science (CMS) at Zewail City. El-Sherbiny earned his Bachelor of Science degree, with honors, in chemistry (top scholar) and his Master of Science degree in polymer chemistry from Mansoura University in Egypt. He was awarded a graduate scholarship from the Egyptian government and a second from Massey University, New Zealand to study for his Doctor of Philosophy degree abroad. He earned his Doctor of Philosophy degree in drug delivery from Massey University in 2007. El-Sherbiny started his professional career as a demonstrator followed by his appointment in 1999 as assistant lecturer at the Faculty of Science, Mansoura University. He also served as a chemistry tutor at the Institute of Fundamental Sciences, Massey University, where he later served as a lab supervisor. From 2008 to 2010, he joined pharmaceuticals research groups as a post-doctoral fellow at at the College of Pharmacy, University of New Mexico and Texas University in the United States. Then El-Sherbiny worked as research assistant professor in the division of pharmaceutics, College of Pharmacy, at the University of Texas starting from 2010. El-Sherbiny’s academic acumen was recognized by being offered a Fulbright Fellowship at the School of Biomedical Engineering, University of Michigan (U.S.) in 2009. He was also awarded several awards including the Prize of late Prof. Abdou Salam in the field of pharmaceuticals and bioproducts, the prestigious Egyptian State Incentive Award in Science, and the Venice Kamel Goda Award for Scientific Creativity for Young Researchers in the field of materials science and its applications. El-Sherbiny was selected among a group of top 40 European Union professors to form the new COST action committee, ""Simm-Inhale”, which focuses on the pulmonary drug delivery’s research. He was also honored by some universities and academies including the Academy of Scientific Research and Technology (ASRT). El-Sherbiny’s research focuses on the design and development of new classes of intelligent nano- and nano-in-micro-polymeric matrices using advanced techniques, and evaluating these new structures as potential candidates in various environmental, biotechnological, and biomedical applications including targeted and controlled drug delivery, tissue engineering, regenerative medicine, and biosensing. Dr. El-Sherbiny has more than 62 scientific papers published in high impact peer-reviewed journals over the last eight years in addition to many more papers in the pipeline. He also has more than 60 participations in international conferences in different countries including France, New Zealand, England, the United Arab Emirates, Jordan, Australia, Turkey, Malaysia, Spain, Canada, and the United States. Dr. El-Sherbiny is the author and co-author of three books, 12 book chapters, and more than seven review articles. He is also a named inventor on 16 patents and patent applications in the U.S., U.K., Europe and Egypt. El-Sherbiny has contributed as a principal investigator and co-principal investigator for more than 15 funded applied research projects in Egypt and the U.S. In addition to El-Sherbiny’s professional experience, he cofounded the Egyptian Organization for Scientific Research and Technology in 2012. He has been a member of different societies and associations including the American Association of Pharmaceutical Scientists, the Biomedical Engineering Society (U.S.), the American Chemical Society, the New Zealand Institute of Chemistry, the Egyptian Chemical Society, the Egyptian Society for Polymer Science & Technology, and the Materials Research Society (U.S.)."

El-Sherbiny’s research focuses on the design and development of new classes of intelligent nano- and nano-in-micro-polymeric matrices using advanced techniques, and evaluating these new structures as potential candidates in various environmental, biotechnological, and biomedical applications including targeted and controlled drug delivery, tissue engineering, regenerative medicine, and biosensing.